The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.
D000828:Animal Population Groups; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology*; D003655:Decerebrate State; D004357:Drug Synergism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006834:Hydrazines / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009647:Normetanephrine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology*
D001949:Bretylium Compounds; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D009647:Normetanephrine; D014316:Tritium; D008750:Methyldopa; D012110:Reserpine; D009526:Nialamide; D009638:Norepinephrine; D014439:Tyramine